NOS3 and diabetes mellitus: In large conduit arteries, it is widely accepted that NO levels are reduced in diabetes (Han et al., 2014) and that changes in the level of endothelial NO synthase (eNOS) and/or increased generation of reactive oxygen species (ROS) such as superoxide may contribute to the reduction of NO production or bioavailability.